Subsequent experiments using tumor samples from the xenograft mouse models revealed significant suppression of DYRK3, PAICS, and Ki-67 proteins in the mice treated with the DYRK3 inhibitor and the combined treatment, relative to the control mice. This evidence concerns the gene DYRK3 and neoplasm.